On the other hand, the contemporary high levels of the pro-inflammatory molecule CXCL10 in TLR3-primed CGD-MSCs may indicate their inability to handle the hyper-inflammatory status typically present in CGD patients. The gene discussed is TLR3; the disease is chronic granulomatous disease.